Insulet | PODD - Creditori Commerciali





Creditori Commerciali Cambiamento Data
Abbott USD 4.24B 117M 2025-12
Align Technology USD 123.72M 2.27M 2026-03
AtriCure USD 70.06M 8.34M 2026-03
Avanos Medical USD 52.3M 3.2M 2026-03
Baxter International USD 1.09B 87M 2026-03
Becton, Dickinson and Co. USD 5.93B 204M 2026-03
Boston Scientific USD 1.14B 3M 2026-03
Cardinal Health USD 37.83B 1.16B 2026-03
Cooper Companies USD 233.3M 7.5M 2026-03
Dexcom USD 1.94B 109.1M 2026-03
Edwards Lifesciences USD 181.1M 46.4M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Globus Medical USD 103.66M 4.81M 2026-03
ICU Medical USD 173.98M 19.61M 2026-03
Inogen USD 21.22M 684K 2025-09
Insulet USD 149.8M 74.8M 2026-03
Integra LifeSciences USD 87.95M 7.78M 2026-03
J&J USD 10.46B 1.53B 2026-03
Masimo USD 89M 14M 2026-03
Medtronic USD 2.57B 12M 2025-12
Merit Medical Systems USD 67.85M 7.3M 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Solventum Corp USD 699M 12M 2026-03
Stryker USD 1.8B 301M 2025-12
Tandem Diabetes Care USD 59.86M 12.79M 2026-03
Teleflex USD 143.63M 13.43M 2026-03
West Pharmaceutical Services USD 252.3M 1.4M 2026-03
Zimmer Biomet Holdings USD 361.2M 58.2M 2026-03